Back

Medicus Pharma secures Pfizer license as shares plunge 32.24%

Verifying
  • Medicus Pharma secured Pfizer's exclusive, sublicensable global license for CD228V.
  • 32.24%: Medicus Pharma shares fell to 18 cents Thursday.
  • Pfizer retains patent ownership and co-development oversight under the agreement.
The information on this website is generated using AI and we cannot guarantee its accuracy. Please use it as reference information only.